Australia markets open in 9 hours 53 minutes

AVITA Medical, Inc. (AVH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
2.5200+0.0200 (+0.80%)
At close: 04:10PM AEST
Full screen
Previous close2.5000
Open2.4800
Bid2.5600 x 734600
Ask2.5500 x 258500
Day's range2.4600 - 2.5600
52-week range2.3800 - 6.2700
Volume416,735
Avg. volume341,703
Market cap325.077M
Beta (5Y monthly)1.42
PE ratio (TTM)N/A
EPS (TTM)-0.5300
Earnings date08 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.45
  • GlobeNewswire

    AVITA Medical to Host Investor Webinar Briefing

    VALENCIA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on May 21, 2024, at 4:00 p.m. Pacific Daylight Time / May 22, 2024, at 9:00 a.m. Au

  • GuruFocus.com

    AVITA Medical Inc (AVHHL) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...

    Despite a challenging quarter, AVITA Medical Inc (AVHHL) reaffirms full-year revenue guidance and progresses on strategic initiatives.

  • GlobeNewswire

    AVITA Medical Reports First Quarter Financial Results

    VALENCIA, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the first quarter ended March 31, 2024. Financial Results and Recent Business Updates Commercial revenue increased approximately 5.8% to $11.1 million compared to the same period in 2023Gross profit margin of 86.4%Launched PermeaDerm,